Healium

Healium IntelliScan is a medical technology company developing an AI-enhanced ultrasound device for the early detection and management of Chronic Kidney Disease (CKD). The company was founded in 2020 by CEO Dr. Biju Jacob and CTO Neeraj Kumar, who met during the Entrepreneur First program in Singapore with a shared goal of improving access to medical diagnostics through AI.

The company's core product is its AI-Point-of-Care Ultrasound (AI-PoCUS) device, which is designed to be non-invasive and provide predictive insights into the cause of CKD. The technology leverages AI-powered digital biomarkers, real-time quality evaluation, and advanced algorithms to analyze ultrasound images, enabling healthcare professionals of varying skill levels to perform high-quality renal ultrasounds. It aims to detect CKD years earlier than traditional methods. The device generates patient-specific perfusion models and 3D kidney representations to improve diagnostic precision. In 2024, Healium IntelliScan submitted its device for FDA 510(k) clearance.

Healium IntelliScan operates on a business-to-business model, targeting radiologists and hospitals. The platform is designed to streamline the entire workflow, from case management to interpretation and reporting. The company has secured seed funding from investors including Brinc, ML Elevate, and Artesian Venture Partners.

Keywords: chronic kidney disease, CKD, AI-powered ultrasound, medical diagnostics, renal imaging, health-tech, diagnostic equipment, AI-PoCUS, digital biomarkers, medical device, early detection, predictive analytics, perfusion modeling, FDA 510(k), non-invasive diagnostics, renal sonography, AI algorithms, healthcare technology, medical imaging, ultrasound technology